Registry to Document Treatment Effectiveness, Safety, Including Prospective Long-term Outcomes in Participants with Progressive Familial Intrahepatic Cholestasis (PFIC) who take Odevixibat (Bylvay) First published 26/09/2025 Last updated 03/02/2026 EU PAS number:EUPAS1000000679 Study Ongoing